United States Pharmaceutical Supply Chain Review Act

Summary

United States Pharmaceutical Supply Chain Review Act This bill requires the Federal Trade Commission to submit annually to Congress a report on foreign investment in the U.S. pharmaceutical industry. The report shall address, among other topics, the effect of the industry's reliance on foreign manufacturing.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 26 April 2021

   Introduced

   Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.

   Source: IntroReferral

2. 26 April 2021

   Introduced

   Introduced in Senate

   Source: IntroReferral

Votes

No vote records are attached yet.

Versions

• Introduced in Senate · 26 April 2021 · Official file

Documents

3 official files

• Introduced in Senate (text)

  Introduced in Senate · EN · 26 April 2021

  ViewDownloadOpen at official source

• Introduced in Senate (PDF)

  Introduced in Senate · EN · 26 April 2021

  ViewDownloadOpen at official source

• Introduced in Senate

  summary · EN · 26 April 2021

  Open at official source

Sponsors

• Elizabeth Warren · D · Sponsor
• Sen. Rubio, Marco [R-FL] · R · Sponsor
• · ssbk00 · Standing

Related records

• related to → Pharmaceutical Supply Chain Defense and Enhancement Act
• related to ← United States Pharmaceutical Supply Chain Review Act